New combo pill for high cholesterol shows promise in Late-Stage trial
NCT ID NCT06955104
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 30 times
Summary
This phase 3 trial tested whether combining two drugs, JW0108 and C2407, can safely lower LDL (bad) cholesterol in people with dyslipidemia. 145 adults took part. The main goal was to see how much LDL cholesterol dropped from the start of the study. The trial is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
Conditions
Explore the condition pages connected to this study.